Balance Sheet
Cash Flow Statement
Capital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Accured ExpensesChange in Accured ExpensesChange in CashDepreciation & Amortization (CF)Depreciation & Amortization (CF)Free Cash FlowFree Cash FlowLong-Term Debt IssuancesNet Cash FlowNet Cash FlowNet IncomeOther Working Capital ChangesOther Working Capital ChangesShares Issued
Growth Metrics
Income Statement
Others
Ratios

Skinvisible (SKVI) Depreciation & Amortization (CF) (2016 - 2026)

Skinvisible's Depreciation & Amortization (CF) history spans 16 years, with the latest figure at $5118.0 for Q4 2025.

  • On a quarterly basis, Depreciation & Amortization (CF) rose 1.35% to $5118.0 in Q4 2025 year-over-year; TTM through Dec 2025 was $20239.0, a 0.97% decrease, with the full-year FY2025 number at $20239.0, down 0.97% from a year prior.
  • Depreciation & Amortization (CF) hit $5118.0 in Q4 2025 for Skinvisible, roughly flat from $5118.0 in the prior quarter.
  • Over the last five years, Depreciation & Amortization (CF) for SKVI hit a ceiling of $5937.0 in Q3 2024 and a floor of $4251.0 in Q1 2021.
  • Historically, Depreciation & Amortization (CF) has averaged $4806.2 across 5 years, with a median of $4733.5 in 2022.
  • Biggest five-year swings in Depreciation & Amortization (CF): crashed 56.86% in 2021 and later skyrocketed 30.77% in 2024.
  • Tracing SKVI's Depreciation & Amortization (CF) over 5 years: stood at $4695.0 in 2021, then rose by 0.92% to $4738.0 in 2022, then increased by 0.19% to $4747.0 in 2023, then rose by 6.38% to $5050.0 in 2024, then rose by 1.35% to $5118.0 in 2025.
  • Business Quant data shows Depreciation & Amortization (CF) for SKVI at $5118.0 in Q4 2025, $5118.0 in Q3 2025, and $5063.0 in Q2 2025.